Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...

Related Keywords

Milan ,Lombardia ,Italy ,United States ,New York ,Rosalia Scampoli ,Katie Mcmanus ,International Congress ,Exchange Commission ,Us Drug Enforcement Agency ,Trevi Therapeutics Inc ,Nasdaq ,Jennifer Good ,Human Abuse Potential ,Stifel Biotech Executive Summit ,Cantor Fitzgerald Global Healthcare Conference ,Biopharma Summit ,Trevi Therapeutics ,Private Securities Litigation Reform Act ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Earnings ,